Literature DB >> 7901643

Boost for vaginal microbicides against HIV.

J M Lange, M Karam, P Piot.   

Abstract

Keywords:  Africa; Africa South Of The Sahara; Clinical Research; Conferences And Congresses; Contraception; Contraceptive Agents; Developed Countries; Developing Countries; Diseases; Economic Factors; Europe; Family Planning; Hiv Infections--prevention and control; Infections; International Agencies; Needs; Nonoxynol-9; Northern Europe; Organizations; Reproductive Tract Infections; Research Methodology; Sexually Transmitted Diseases--prevention and control; Spermicidal Contraceptive Agents; Un; United Kingdom; Viral Diseases; Who

Mesh：

Substances：

Year:  1993        PMID： 7901643     DOI： 10.1016/0140-6736(93)92258-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

Authors:  M R Boyd; K R Gustafson; J B McMahon; R H Shoemaker; B R O'Keefe; T Mori; R J Gulakowski; L Wu; M I Rivera; C M Laurencot; M J Currens; J H Cardellina; R W Buckheit; P L Nara; L K Pannell; R C Sowder; L E Henderson
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

2.  Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.

Authors:  M T Esser; T Mori; I Mondor; Q J Sattentau; B Dey; E A Berger; M R Boyd; J D Lifson
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.

Authors:  Radiana T Trifonova; Jenna-Malia Pasicznyk; Raina N Fichorova
Journal:  Antimicrob Agents Chemother       Date:  2006-10-09       Impact factor: 5.191

4.  Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia.

Authors:  S K Hira; A B Spruyt; P J Feldblum; M R Sunkutu; L H Glover; M J Steiner
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

Review 5.  Silencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSV.

Authors:  Lee Adam Wheeler
Journal:  Infect Dis Obstet Gynecol       Date:  2014-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.